Tag

Emergent Biosolutions

All articles tagged with #emergent biosolutions

business3 years ago•1 min saved

Emergent BioSolutions Implements Major Workforce Reduction, Cuts 400 Jobs

Emergent BioSolutions, a biotech company, has announced plans to lay off approximately 400 employees and scale back operations at some of its facilities. The company aims to focus on core products such as the overdose reversal nasal spray Narcan and anthrax vaccines, moving away from contract drug development and manufacturing. The job cuts, along with other initiatives, are expected to save over $100 million annually. Smaller biotech companies have been struggling to finance drug development programs, impacting their ability to deliver contract research services. Emergent expects to incur an estimated cost of $19-21 million in the third quarter of 2023.

via Reuters|

#business #cost-reduction #drug-development

healthcare3 years ago•1 min saved

Narcan maker plans to sell overdose antidote for under $50 over-the-counter.

Emergent BioSolutions, the manufacturer of Narcan, aims to reduce the wholesale price of the overdose reversal drug to around $50 per carton from the current $125 per carton. The FDA recently approved sales of Narcan without a prescription, expanding access to the drug in areas with significant overdose problems and lacking pharmacies. However, the final price and insurance coverage for Narcan remain uncertain. Emergent acknowledges that maintaining affordability will require collaboration between government leaders, retailers, and other key stakeholders.

via Fox Business|

#affordability #emergent-biosolutions #fda

health3 years ago•4 min saved

Narcan to be sold over-the-counter for under $50 per kit.

Drugmaker Emergent BioSolutions announced that the over-the-counter nasal spray Narcan, which reverses opioid overdoses, will sell for "less than $50" per kit. However, advocates worry that the price may be a barrier for those who need it the most. Emergent said its kits will be on store shelves and available for purchase online by late summer. The company did not cite an exact price, but its "goal" is for the retail price to be "consistent with our public interest price." The president of the National Council for Mental Wellbeing said a price near $50 is "too high for the average person," especially because some overdose victims may require multiple doses of the spray.

via The Washington Post|

#drug-overdose #emergent-biosolutions #health

pharmaceuticals3 years ago•6 min saved

J&J drops out of RSV vaccine race with Pfizer and GSK.

Johnson & Johnson has ended development of its adult RSV vaccine in the middle of a 27,200-patient trial, citing a shifting competitive landscape. Emergent BioSolutions' Narcan brand naloxone nasal spray has been approved by the FDA for over-the-counter sales. AstraZeneca has scrapped its license agreement with Aridis Pharmaceuticals, putting a European-funded Phase III trial on hold.

via Endpoints News|

#astrazeneca #emergent-biosolutions #johnson-and-johnson